Biotech in the Big Easy

The Scientist has journeyed down to New Orleans to assess its burgeoning R&D efforts. And the state-financed New Orleans BioInnovation Center is getting credit for helping start-ups bridge the gap between innovation in the lab and products in the market. Story

Suggested Articles

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.